Comparison between Affle IPO and Metropolis Healthcare IPO.
Affle IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Metropolis Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Affle IPO is up to ₹459.00 Cr whereas the issue size of the Metropolis Healthcare IPO is up to ₹1,204.29 Cr. The final issue price of Affle IPO is ₹745.00 per share and of Metropolis Healthcare IPO is ₹880.00 per share.
| Affle IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹740.00 per share | ₹877.00 per share |
| Issue Price (Upper) | ₹745.00 per share | ₹880.00 per share |
| Issue Price (Final) | ₹745.00 per share | ₹880.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 20 shares | 17 shares |
| Fresh Issue Size | 12,08,053 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹90.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 49,53,020 shares | 1,36,85,095 shares |
| OFS Issue Size (Amount) | up to ₹369.00 Cr | up to ₹1,204.29 Cr |
| Issue Size Total | 61,61,073 shares | 1,36,85,095 shares |
| Issue Size Total (Amount) | up to ₹459.00 Cr | up to ₹1,204.29 Cr |
Affle IPO opens on Jul 29, 2019, while Metropolis Healthcare IPO opens on Apr 03, 2019. The closing date of Affle IPO and Metropolis Healthcare IPO is Jul 31, 2019, and Apr 05, 2019, respectively.
| Affle IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Jul 26, 2019 | Apr 02, 2019 |
| Issue Open | Jul 29, 2019 | Apr 03, 2019 |
| Issue Close | Jul 31, 2019 | Apr 05, 2019 |
| Basis Of Allotment (Tentative) | Aug 05, 2019 | Apr 10, 2019 |
| Initiation of Refunds (Tentative) | Aug 06, 2019 | Apr 11, 2019 |
| Credit of Share (Tentative) | Aug 07, 2019 | Apr 12, 2019 |
| Listing date (Tentative) | Aug 08, 2019 | Apr 15, 2019 |
| Anchor Lockin End date 1 | Sep 04, 2019 | May 10, 2019 |
| Anchor Lockin End date 2 | Nov 03, 2019 | Jul 09, 2019 |
Affle IPO P/E ratio is , as compared to Metropolis Healthcare IPO P/E ratio of .
| Affle IPO | Metropolis Healthcare IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 92.17 | 99.71 | ||||
| Promoter Shareholding (Post-Issue) | 68.4 | 49.44 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1899.48 Cr. | ₹4415.72 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Affle IPO Retail Individual Investors (RII) are offered 6,16,107 shares while in Metropolis Healthcare IPO retail investors are offered 6,16,107 shares. Qualified Institutional Buyers (QIB) are offered 18,48,323 shares in Affle IPO and 40,15,529 shares in Metropolis Healthcare IPO.
| Affle IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 27,72,483 shares | 60,23,293 shares |
| Market Maker Reservation | ||
| QIB | 18,48,323 shares | 40,15,529 shares |
| NII | 9,24,160 shares | 20,07,764 shares |
| RII | 6,16,107 shares | 13,38,509 shares |
| Employee | 3,00,000 shares | |
| Others | ||
| Total | 61,61,073 shares | 1,36,85,095 shares |
Affle IPO subscribed 86.48x in total, whereas Metropolis Healthcare IPO subscribed 5.83x.
| Affle IPO | Metropolis Healthcare IPO | |
|---|---|---|
| QIB (times) | 55.31x | 8.88x |
| NII (times) | 198.69x | 3.03x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.94x | 2.15x |
| Employee (times) | 0.05x | |
| Other (times) | ||
| Total (times) | 86.48x | 5.83x |
